1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012;379:1245-1255.
3. Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-773.
4. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology 2002;60:40-49.
5. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998;37:171-186.
6. Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol 2013;58:89-97.
7. Lee FT Jr, Chosy SG, Littrup PJ, Warner TF, Kuhlman JE, Mahvi DM. CT-monitored percutaneous cryoablation in a pig liver model: pilot study. Radiology 1999;211:687-692.
8. Silverman SG, Sun MR, Tuncali K, Morrison PR, vanSonnenberg E, Shankar S, et al. Three-dimensional assessment of MRI-guided percutaneous cryotherapy of liver metastases. AJR Am J Roentgenol 2004;183:707-712.
9. Gilbert JC, Onik GM, Hoddick WK, Rubinsky B. Real time ultrasonic monitoring of hepatic cryosurgery. Cryobiology 1985;22:319-330.
10. Tacke J, Adam G, Haage P, Sellhaus B, Grosskortenhaus S, Günther RW. MR-guided percutaneous cryotherapy of the liver: in vivo evaluation with histologic correlation in an animal model. J Magn Reson Imaging 2001;13:50-56.
11. Permpongkosol S, Sulman A, Solomon SB, Gong GX, Kavoussi LR. Percutaneous computerized tomography guided renal cryoablation using local anesthesia: pain assessment. J Urol 2006;176:915-918.
12. Allaf ME, Varkarakis IM, Bhayani SB, Inagaki T, Kavoussi LR, Solomon SB. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations. Radiology 2005;237:366-370.
14. Hinshaw JL, Lee FT. Cryoablation for liver cancer. Tech Vasc Interv Radiol 2007;10:47-57.
15. Weber SM, Lee FT Jr, Warner TF, Chosy SG, Mahvi DM. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology 1998;207:73-77.
16. Rivoire ML, Voiglio EJ, Kaemmerlen P, Molina G, Treilleux I, Finzy J, et al. Hepatic cryosurgery precision: evaluation of ultrasonography, thermometry, and impedancemetry in a pig model. J Surg Oncol 1996;61:242-248.
17. Smith JJ, Fraser J. An estimation of tissue damage and thermal history in the cryolesion. Cryobiology 1974;11:139-147.
18. Smith JJ, Fraser J, MacIver AG. Ultrastructure after cryosurgery of rat liver. Cryobiology 1978;15:426-432.
19. Permpongkosol S, Nicol TL, Link RE, Varkarakis I, Khurana H, Zhai QJ, et al. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol. AJR Am J Roentgenol 2007;188:1028-1032.
20. Ikekawa S, Ishihara K, Tanaka S, Ikeda S. Basic studies of cryochemotherapy in a murine tumor system. Cryobiology 1985;22:477-483.
21. Zacarian SA. The observation of freeze-thaw cycles upon cancer-cell suspensions. J Dermatol Surg Oncol 1977;3:173-174.
22. Seifert JK, Gerharz CD, Mattes F, Nassir F, Fachinger K, Beil C, et al. A pig model of hepatic cryotherapy. In vivo temperature distribution during freezing and histopathological changes. Cryobiology 2003;47:214-226.
23. Niu LZ, Li JL, Xu KC. Percutaneous Cryoablation for Liver Cancer. J Clin Transl Hepatol 2014;2:182-188.
24. Whittaker DK. Repeat freeze cycles in cryosurgery of oral tissues. Br Dent J 1975;139:459-465.
25. Mala T, Edwin B, Tillung T, Kristian Hol P, Søreide O, Gladhaug I. Percutaneous cryoablation of colorectal liver metastases: potentiated by two consecutive freeze-thaw cycles. Cryobiology 2003;46:99-102.
26. Muller-Schweinitzer E. Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at -196 degrees C. Cryobiology 1994;31:330-335.
27. Clarke DM, Robilotto AT, Rhee E, VanBuskirk RG, Baust JG, Gage AA, et al. Cryoablation of renal cancer: variables involved in freezing-induced cell death. Technol Cancer Res Treat 2007;6:69-79.
28. Li J, Chen J, Zhou L, Zeng J, Yao F, Wu B, et al. Comparison of dual-and triple-freeze protocols for hepatic cryoablation in a Tibet pig model. Cryobiology 2012;65:68-71.
29. Lee SM, Won JY, Lee DY, Lee KH, Lee KS, Paik YH, et al. Percutaneous cryoablation of small hepatocellular carcinomas using a 17-gauge ultrathin probe. Clin Radiol 2011;66:752-759.
31. Wang C, Wang H, Yang W, Hu K, Xie H, Hu KQ, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology 2015;61:1579-1590.
32. Ei S, Hibi T, Tanabe M, Itano O, Shinoda M, Kitago M, et al. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the tool-box. Ann Surg Oncol 2015;22:1294-1300.
33. Cozzi PJ, Stewart GJ, Morris DL. Thrombocytopenia after hepatic cryotherapy for colorectal metastases: correlates with hepatocellular injury. World J Surg 1994;18:774-776.
34. Hamad GG, Neifeld JP. Biochemical, hematologic, and immunologic alterations following hepatic cryotherapy. Semin Surg Oncol 1998;14:122-128.
35. Onik G, Rubinsky B, Zemel R, Weaver L, Diamond D, Cobb C, et al. Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer 1991;67:901-907.
36. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am J Surg 1996;171:27-31.
37. Nair RT, Silverman SG, Tuncali K, Obuchowski NA, vanSonnenberg E, Shankar S. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology 2008;248:303-311.
38. Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592-599.
39. Tait IS, Yong SM, Cuschieri SA. Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg 2002;89:1613-1619.
40. Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000;135:657-662 discussion 662-654.
41. Adam R, Hagopian EJ, Linhares M, Krissat J, Savier E, Azoulay D, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002;137:1332-1339 discussion 1340.
42. Huang YZ, Zhou SC, Zhou H, Tong M. Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology 2013;60:1131-1135.
43. Dunne RM, Shyn PB, Sung JC, Tatli S, Morrison PR, Catalano PJ, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol 2014;83:632-638.
44. Lee DH, Lee JM, Yoon JH, Kim YJ, Han JK. Thermal Injury-induced Hepatic Parenchymal Hypoperfusion: Risk of Hepatocellular Carcinoma Recurrence after Radiofrequency Ablation. Radiology 2016 Sep 19:152322. [Epub ahead of print].
45. Ku Y, Kusunoki N, Shiotani M, Maeda I, Iwasaki T, Tominaga M, et al. Stimulation of haematogenous liver metastases by ischaemia-reperfusion in rats. Eur J Surg 1999;165:801-807.
46. van der Bilt JD, Kranenburg O, Nijkamp MW, Smakman N, Veenendaal LM, Te Velde EA, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology 2005;42:165-175.
48. Fairchild AH, Tatli S, Dunne RM, Shyn PB, Tuncali K, Silverman SG. Percutaneous cryoablation of hepatic tumors adjacent to the gallbladder: assessment of safety and effectiveness. J Vasc Interv Radiol 2014;25:1449-1455.